©2024 Stanford Medicine
Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
Not Recruiting
Trial ID: NCT01546363
Purpose
The purpose of this study is to measure the levels of serum proteins and other biomarkers in
cervical cancer patients. We believe that some of these markers may be useful in selecting
patients for specific types of cancer therapies. These markers may also help to predict
response to therapy, relapse after therapy, and survival after therapy.
Official Title
Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
Stanford Investigator(s)
Elizabeth Kidd
Associate Professor of Radiation Oncology (Radiation Therapy)
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
Eligibility
Inclusion Criteria:
- Patients must have a known or suspected cervical cancer.
- Age >=18 years.
- Patients must have no other active cancer at the time of diagnosis.
- Patients must have no history of a hysterectomy.
- Patients must be able to give informed consent.
- Patients must be willing to undergo a biopsy of the cervical tumor to provide tissue
for the study.
- Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of
therapy, for assessment of lymph nodes.
Exclusion Criteria:
- Pregnant women
Intervention(s):
other: Blood draw
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Dylann Fujimoto
650-723-8843